125 related articles for article (PubMed ID: 1602602)
21. Nonselective measurement of cyclosporine for therapeutic drug monitoring by fluorescence polarization immunoassay with a rabbit polyclonal antibody: I. Evaluation of the serum methodology and comparison with a sheep polyclonal antibody in an 3H-tracer mediated radioimmunoassay.
Napoli KL; Kahan BD
Transplant Proc; 1990 Jun; 22(3):1175-80. PubMed ID: 2190377
[TBL] [Abstract][Full Text] [Related]
22. Analytical evaluation of TDx cyclosporine and metabolites fluorescence polarization immunoassay and comparison with the Cyclo-Trac RIA kit.
Montojo C; Calvo MV; Domínguez-Gil A
J Clin Pharm Ther; 1990 Feb; 15(1):45-51. PubMed ID: 2180968
[TBL] [Abstract][Full Text] [Related]
23. Comparison of fluorescent polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantation.
Khoschsorur G; Fruehwirth F; Zelzer S; Stettin M; Halwachs-Baumann G
Clin Chim Acta; 2007 May; 380(1-2):217-21. PubMed ID: 17320846
[TBL] [Abstract][Full Text] [Related]
24. Comparative analyses of cyclosporine in whole blood and plasma by radioimmunoassay, fluorescence polarization immunoassay, and high-performance liquid chromatography.
Lindholm A; Henricsson S
Ther Drug Monit; 1990 Jul; 12(4):344-52. PubMed ID: 2396308
[TBL] [Abstract][Full Text] [Related]
25. An evaluation of the cyclosporine parent-compound-specific whole blood TDx assay.
Pescovitz MD; Book BK; Pollard SG; Milgrom ML; Leapman SB; Filo RS
Clin Transplant; 1992 Feb; 6(1):43-7. PubMed ID: 10147649
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the AxSYM monoclonal cyclosporin assay and comparison with radioimmunoassay.
Sabaté I; Ginard M; González JM; Baró E; Acebes G; Cuadros J; Lirón FJ
Ther Drug Monit; 2000 Aug; 22(4):474-80. PubMed ID: 10942190
[TBL] [Abstract][Full Text] [Related]
27. An evaluation of cyclosporine monitoring by nonselective fluorescence polarization immunoassay.
Pesce AJ; Schroeder TJ; First MR
Transplant Proc; 1990 Jun; 22(3):1171-4. PubMed ID: 2190376
[No Abstract] [Full Text] [Related]
28. The measurement of whole blood pre-treatment cyclosporine A: metabolite ratios predicts the onset of renal dysfunction in recipients of allogeneic stem cell transplantation.
Stephens E; Bolderson I; Clark B; Kinsey S; Gooi HC; Cook G
Ann Clin Biochem; 2006 Sep; 43(Pt 5):382-8. PubMed ID: 17022881
[TBL] [Abstract][Full Text] [Related]
29. [The correlation between the polyomavirus DNA load and the dose of immunosuppressant].
Cai P; Teng ZP; Wu T; Zhang JF; Liu Y; Wang Z; Zheng WX; Xu GL; Tong CR
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):272-4. PubMed ID: 19105341
[TBL] [Abstract][Full Text] [Related]
30. A comparison of cyclosporine assays using sequential samples from selected transplant patients.
LeGatt DF; Coates JE; Simpson AI; Shalapay CE; Rintoul BJ; Yatscoff RW
Clin Biochem; 1994 Feb; 27(1):43-8. PubMed ID: 8200114
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of fluorescence polarization immunoassay for determination of cyclosporin in plasma.
Hayashi Y; Shibata N; Minouchi T; Shibata H; Ono T; Shimakawa H
Ther Drug Monit; 1989; 11(2):205-9. PubMed ID: 2655204
[TBL] [Abstract][Full Text] [Related]
32. Effects of different routes of cyclosporin A administration on blood levels in patients undergoing bone marrow transplantation.
Capone D; De Marino V; Fontana R; Notaro R; De Marino V; Pisanti N
Bone Marrow Transplant; 1997 Feb; 19(4):369-72. PubMed ID: 9051247
[TBL] [Abstract][Full Text] [Related]
33. Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humans.
Hinterberger-Fischer M; Kier P; Spona J; Sebesta C; Tiefengraber E; Habertheuer KH; Ruckser R; Schmid A; Kalhs P; Lechner K
Bone Marrow Transplant; 1994 Sep; 14(3):403-6. PubMed ID: 7994262
[TBL] [Abstract][Full Text] [Related]
34. Comparison of whole-blood cyclosporine levels measured by radioimmunoassay and fluorescence polarization in patients post orthotopic liver transplant.
Hooks MA; Millikan WJ; Henderson JM; Mullins R; Lampasona V
Ther Drug Monit; 1989; 11(3):304-9. PubMed ID: 2658211
[TBL] [Abstract][Full Text] [Related]
35. An evaluation of the cyclosporine and metabolites whole blood TDx assay.
Schroeder TJ; Pesce AJ; Hindenlang LL; Mauser PA; Ruckrigl DL; Weibel ML; Wadih G; First MR
Ther Drug Monit; 1989; 11(4):480-2. PubMed ID: 2662481
[TBL] [Abstract][Full Text] [Related]
36. The determination of metabolite M17 and its meaning for immunosuppressive cyclosporin therapy.
Khoschsorur G; Auer T; Lanzer G; Petritsch P; Holzer H; Tscheliessnigg KH
Angiology; 1998 Apr; 49(4):307-14. PubMed ID: 9555934
[TBL] [Abstract][Full Text] [Related]
37. Cyclosporine A assays: comparison between radioimmunoassay and fluorescent polarization immunoassay technique by TDx, and the clinical significance of the polyclonal:monoclonal TDx ratio.
McKenna BA; Pabico RC; Cerilli GJ
Transplant Proc; 1994 Oct; 26(5):2818-9. PubMed ID: 7940886
[No Abstract] [Full Text] [Related]
38. [Measuring cyclosporin in immunosuppressive treatment following liver and heart transplantation].
Hamilton G; Roth E; Mühlbacher F; Funovics J; Piza F; Schindler J; Woloszcuk W; Havel M; Laczkovics A
Wien Klin Wochenschr; 1986 Dec; 98(24):820-4. PubMed ID: 3548080
[TBL] [Abstract][Full Text] [Related]
39. Japanese conference on cyclosporine blood level monitoring.
Takagi H; Uchida K
Transplant Proc; 1990 Jun; 22(3):1224-5. PubMed ID: 2190384
[No Abstract] [Full Text] [Related]
40. A review of assay methods for cyclosporin. Clinical implications.
Kivistö KT
Clin Pharmacokinet; 1992 Sep; 23(3):173-90. PubMed ID: 1511535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
